Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1320

1.

Is testosterone important in LUT function in men and women? ICI-RS 2015.

Badawi JK, Bosch R, Djurhuus JC, Hanna-Mitchell AT.

Neurourol Urodyn. 2017 Apr;36(4):859-862. doi: 10.1002/nau.23041. Review.

PMID:
28444714
2.

Sex differences in the presentation of stroke.

Berglund A, Schenck-Gustafsson K, von Euler M.

Maturitas. 2017 May;99:47-50. doi: 10.1016/j.maturitas.2017.02.007. Epub 2017 Feb 16. Review.

PMID:
28364868
3.

CE: Overactive Bladder in Women.

Palmer MH, Willis-Gray MG.

Am J Nurs. 2017 Apr;117(4):34-41. doi: 10.1097/01.NAJ.0000515207.69721.94.

PMID:
28282306
4.

Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.

Maund E, Guski LS, Gøtzsche PC.

CMAJ. 2017 Feb 6;189(5):E194-E203. doi: 10.1503/cmaj.151104. Epub 2016 Nov 14.

5.

Deinfibulation for treating urologic complications of type III female genital mutilation: A systematic review.

Effa E, Ojo O, Ihesie A, Meremikwu MM.

Int J Gynaecol Obstet. 2017 Feb;136 Suppl 1:30-33. doi: 10.1002/ijgo.12045. Review.

PMID:
28164295
6.

Urinary incontinence in women: non pharmacologic approaches and newer pharmacotherapies. An update.

Kowalik CG, Cohn JA, Gomelsky A, Dmochowski RR.

Minerva Med. 2017 Jun;108(3):255-267. doi: 10.23736/S0026-4806.17.05009-1. Epub 2017 Jan 17. Review.

PMID:
28094490
7.

Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.

Kosilov KV, Loparev S, Kuzina I, Shakirova O, Zhuravskaya N, Lobodenko A.

Ther Adv Urol. 2016 Aug;8(4):239-248. Epub 2016 Jun 3.

8.

Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids: Signaling pathways as target.

Islam MS, Segars JH, Castellucci M, Ciarmela P.

Pharmacol Rep. 2017 Feb;69(1):57-70. doi: 10.1016/j.pharep.2016.10.013. Epub 2016 Oct 20. Review.

PMID:
27898339
9.

Efficacy of FemiScan Pelvic Floor Therapy for the Treatment of Urinary Incontinence.

Segal S, Morse A, Sangal P, Hirsch N, Kohli N.

Female Pelvic Med Reconstr Surg. 2016 Nov/Dec;22(6):433-437.

PMID:
27636211
10.

Methodology for a trial of brain-centered versus anticholinergic therapy in women with urgency urinary incontinence.

Komesu YM, Rogers RG, Sapien RE, Schrader RM, Simmerman-Sierra T, Mayer AR, Ketai LH.

Int Urogynecol J. 2017 Jun;28(6):865-874. doi: 10.1007/s00192-016-3169-3. Epub 2016 Oct 17.

PMID:
27752750
11.

A short review of drug-food interactions of medicines treating overactive bladder syndrome.

Paśko P, Rodacki T, Domagała-Rodacka R, Owczarek D.

Int J Clin Pharm. 2016 Dec;38(6):1350-1356. Epub 2016 Oct 13. Review.

12.

OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.

Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, Myers DL, Zyczynski HM, Vasavada S, Nolen TL, Wallace D, Meikle SF.

JAMA. 2016 Oct 4;316(13):1366-1374. doi: 10.1001/jama.2016.14617.

13.

Endocrine therapy and urogenital outcomes among women with a breast cancer diagnosis.

Landi SN, Doll KM, Bensen JT, Hendrix L, Anders CK, Wu JM, Nichols HB.

Cancer Causes Control. 2016 Nov;27(11):1325-1332. Epub 2016 Sep 28.

PMID:
27680018
14.

Prevalence and factors associated with urinary incontinence in climacteric.

Dellú MC, Schmitt AC, Cardoso MR, Pereira WM, Pereira EC, Vasconcelos Éda S, Aldrighi JM.

Rev Assoc Med Bras (1992). 2016 Sep-Oct;62(5):441-6. doi: 10.1590/1806-9282.62.05.441.

15.

Comparison of the effectiveness of repeated injections of onabotulinum toxin A for refractory idiopathic detrusor overactivity: analysis of an open label extension of a randomized trial (the RELAX study).

Owen RK, Abrams KR, Mayne C, Slack M, Tincello DG.

Neurourol Urodyn. 2017 Apr;36(4):1201-1207. doi: 10.1002/nau.23095. Epub 2016 Aug 26.

PMID:
27564599
17.

[Physiotherapy in Women with Overactive Bladder].

Henscher U, Tholen R, Kirschner-Hermanns R.

Aktuelle Urol. 2016 Aug;47(4):310-4. doi: 10.1055/s-0042-103986. Epub 2016 Aug 8. German.

PMID:
27500849
18.

Polyethylene Glycol 3350 and Docusate Sodium Compared With Docusate Sodium Alone After Urogynecologic Surgery: A Randomized Controlled Trial.

Edenfield AL, Siddiqui NY, Wu JM, Dieter AA, Garrett MA, Visco AG.

Obstet Gynecol. 2016 Sep;128(3):543-9. doi: 10.1097/AOG.0000000000001565.

PMID:
27500338
19.

Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management.

Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA.

Am J Obstet Gynecol. 2016 Dec;215(6):704-711. doi: 10.1016/j.ajog.2016.07.045. Epub 2016 Jul 26. Review.

PMID:
27472999
20.

[Motor levodopa-induced complications in Parkinson's disease].

Michałowska M, Fiszer U, Szatanowski T.

Pol Merkur Lekarski. 2016 Jun;40(240):357-61. Polish.

PMID:
27403901

Supplemental Content

Loading ...
Support Center